Australian startups receive $18.5 M to commercialise research to cure blindness, find cancer, and make childbirth safer

The Australian government is investing $18.5 million to help eight Australian startup companies to commercialise their r...

December 23, 2024 | Monday | News
Singapore bioengineers yeast microbes as targeted drug delivery systems

Researchers from the Yong Loo Lin School of Medicine (NUS Medicine) in Singapore have developed a groundbreaking way to ...

December 18, 2024 | Wednesday | News
Major milestone for UQ spin-out’s promising MND drug in Australia

A potential new treatment for motor neurone disease (MND) developed by a company spun-out of The University of Queenslan...

December 11, 2024 | Wednesday | News
First international progressive supranuclear palsy research and treatment centre opens in Korea

Seoul National University Bundang Hospital (SNUBH), CurePSP, Inc. and GemVax & KAEL Co., have announced the est...

December 9, 2024 | Monday | News
Alamar Biosciences establishes commercial presence in Asia Pacific region

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, has announced i...

December 7, 2024 | Saturday | News
World-first cream to treat skin cancer moves closer to reality

A topical cream to help prevent and treat skin cancers in organ transplant patients is a step closer to development. The...

November 30, 2024 | Saturday | News
Australian government invests $50 M towards finding cure for Type 1 diabetes

The Albanese government is supporting the next phase of the search for a cure for Type 1 Diabetes through a $50.1 millio...

November 28, 2024 | Thursday | News
CADENCE and Medera launch Asia’s First Multi-Centre Gene Therapy Trial in Singapore for Heart failure

The Cardiovascular Disease National Collaborative Enterprise (CADENCE) and Medera Inc. (“Merdera”)’s S...

November 19, 2024 | Tuesday | News
Kaken Pharmaceutical and Numab Therapeutics collaborate on inflammatory bowel disease treatment

Numab Therapeutics AG, a clinical stage biotechnology company advancing a proprietary pipeline of multi-specific antibod...

November 15, 2024 | Friday | News
Lilly expands R&D footprint in Singapore with S$42 M investment in new Digital Health Innovation Hub

Lilly Digital Health and Lilly Centre for Clinical Pharmacology (LCCP), a wholly owned subsidiary of U.S.-based Eli Lill...

November 14, 2024 | Thursday | News
Scientists in Singapore use microcellular drones to deliver lung cancer-killing drugs

A team of researchers, led by Assistant Professor Minh Le from the Institute for Digital Medicine (WisDM) and Department...

November 13, 2024 | Wednesday | News
Singapore's Duke-NUS research unlocks precision therapy for drug-resistant leukaemia

Scientists from Singapore's Duke-NUS Medical School and their collaborators have identified an inherited genetic variati...

November 7, 2024 | Thursday | News
“Moving forward, cancer may not be a death threat but a manageable disease with strong control”

Could you explain more about the advantages of using iPSCs from cord blood for creating your ‘off-the-shelf’...

October 31, 2024 | Thursday | Opinion
Digital Innovations in Diabetes Care

Diabetes affects 1 in 11 adults, or about 90 million people, in South-East Asia, with this number projected to rise to 1...

October 31, 2024 | Thursday | Analysis
Merck invests $76 M to expand ADC manufacturing for novel cancer therapies

MilliporeSigma, the US and Canada Life Science business of Merck KGaA, Darmstadt, Germany, has announced a $76 million e...

October 30, 2024 | Wednesday | News
Seaport Therapeutics secures $225 M funding to develop neuropsychiatric medicines using prodrug technology

The clinical-stage biopharmaceutical company, Seaport Therapeutics, which uses a unique drug delivery platform orig...

October 26, 2024 | Saturday | News
HELP Therapeutics Secures FDA Approval for Phase I Study of HiCM-188 in Heart Failure Treatment

HELP Therapeutics Co. Ltd, a clinical-stage cell therapy company, announced that the U.S. Food and Drug Administrat...

October 22, 2024 | Tuesday | News
Isolere Bio by Donaldson Launches Research-Grade IsoTag™ AAV Reagent for Rapid, Non-Chromatographic Viral Vector Purification

Isolere Bio by Donaldson, an innovative bioprocessing technology provider, proudly announces the availability of researc...

October 18, 2024 | Friday | News